This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -14.46% and +14.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BBIOPositive Net Change AMPHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Devon Energy (DVN) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Devon Energy (DVN) delivered earnings and revenue surprises of +1.20% and +6.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DVNPositive Net Change HPKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Grocery Outlet Holding Corp. (GO) Tops Q2 Earnings Estimates
by Zacks Equity Research
Grocery Outlet (GO) delivered earnings and revenue surprises of +35.29% and -0.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GONegative Net Change TBBBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Jazz (JAZZ) delivered earnings and revenue surprises of -34.80% and -0.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JAZZPositive Net Change IMNMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Jushi Holdings Inc. (JUSHF) delivered earnings and revenue surprises of 0.00% and +0.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JUSHFPositive Net Change ACBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
comScore (SCOR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
comScore (SCOR) delivered earnings and revenue surprises of -317.46% and +1.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SCORNegative Net Change BVPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Advanced Energy Industries (AEIS) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Advanced Energy (AEIS) delivered earnings and revenue surprises of +17.19% and +5.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AEISPositive Net Change SNCRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Amgen (AMGN) delivered earnings and revenue surprises of +14.45% and +3.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMGNNegative Net Change ABSINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arista Networks (ANET) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Arista Networks (ANET) delivered earnings and revenue surprises of +12.31% and +4.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ANETPositive Net Change DBDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
DaVita HealthCare (DVA) delivered earnings and revenue surprises of +9.26% and +1.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DVAPositive Net Change PNTGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Littelfuse (LFUS): Time to Buy?
by Zacks Equity Research
Littelfuse (LFUS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
LFUSPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Western Digital (WDC): Time to Buy?
by Zacks Equity Research
Western Digital (WDC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
WDCNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Udemy (UDMY): Will It Gain?
by Zacks Equity Research
Udemy, Inc. (UDMY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
UDMYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can PTC Inc. (PTC) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
PTC Inc. (PTC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
PTCPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Amicus Therapeutics (FOLD): Time to Buy?
by Zacks Equity Research
Amicus Therapeutics (FOLD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FOLDPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Evercore (EVR): Time to Buy?
by Zacks Equity Research
Evercore (EVR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EVRPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Newmont (NEM): Will It Gain?
by Zacks Equity Research
Newmont Corporation (NEM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
NEMPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Celestica (CLS): Time to Buy?
by Zacks Equity Research
Celestica (CLS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CLSNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Will Burlington Stores (BURL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Burlington Stores (BURL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BURLNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Franco-Nevada (FNV) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Franco-Nevada (FNV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FNVPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Canadian Imperial Bank (CM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Canadian Imperial Bank (CM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CMNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MDTNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Ulta (ULTA) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Ulta (ULTA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ULTAPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy
by Zacks Equity Research
Indivior (INDV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
INDVNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Northfield (NFBK) Rating Upgrade to Buy
by Zacks Equity Research
Northfield (NFBK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
NFBKNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank